DMRA Damora Therapeutics, Inc. - Common Stock

NASDAQ · · Lihat di SEC EDGAR ↗
$30,81
Harga · Agu 18, 2026
Fundamental per Agu 10, 2026
Rentang 52M
$19–$35
75% of range
Peringkat Analis
BUY
16 analysts
Target Harga
$45
+45% upside
P/E (TTM)
—
ROE
-167.0%
Margin Laba Bersih
-17981.1%

DMRA Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

Harga
$30.81
Kapitalisasi Pasar
—
P/E (TTM)
—
EPS (TTM)
$3.98
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
-167.0%
D/E Utang/Ekuitas
—
Rentang 52M
$19 – $35

DMRA Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

Pendapatan & Laba Bersih —
EPS $3.98
5-point trend, +294.1%
2021-12-31 → 2025-12-31
Arus Kas Bebas —
2-point trend, +17.9%
2021-12-31 → 2022-12-31
Margin -17981.1%

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik
Tren 5 Tahun
DMRA
Median Rekan

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik
Tren 5 Tahun
DMRA
Median Rekan
Operating Margin (Margin Operasi)
5-point trend, +46.0%
-18069.6%
—
Net Profit Margin (Margin Laba Bersih)
5-point trend, +45.8%
-17981.1%
—
ROA
5-point trend, -329.0%
-151.2%
—
ROE
5-point trend, -298.2%
-167.0%
—
ROIC
5-point trend, -97.0%
-87.8%
—

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik
Tren 5 Tahun
DMRA
Median Rekan
Current Ratio (Rasio Lancar)
5-point trend, -46.4%
13.0
—
Quick Ratio (Rasio Cepat)
5-point trend, -41.8%
12.8
—

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik
Tren 5 Tahun
DMRA
Median Rekan
Revenue YoY (Pendapatan YoY)
38.3%
—
Revenue CAGR 3Y (CAGR Pendapatan 3T)
17.4%
—

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik
Tren 5 Tahun
DMRA
Median Rekan
EPS (Diluted)
5-point trend, +294.1%
$3.98
—

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik
Tren 5 Tahun
DMRA
Median Rekan

DMRA Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

BELI 16 analis
  • Beli Kuat 6 37,5%
  • Beli 9 56,2%
  • Tahan 1 6,2%
  • Jual 0 0,0%
  • Jual Kuat 0 0,0%

Target Harga 12 Bulan

Target median $45.00 +46,1%
Target rata-rata $44.67 +45,0%

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

Kejutan Rata-rata
1.0%
Periode EPS Aktual EPS Estimasi Kejutan
31 Maret 2026 $-0.62 $-0.40 -0.22%
31 Des. 2025 $2.70 $-0.11 2.8%
31 Des. 2024 $-5.23 $-3.03 -2.2%
30 Sep. 2024 $-3.39 $-4.18 0.79%
30 Juni 2024 $-4.00 $-8.03 4.0%

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

Ticker Kapitalisasi Pasar P/E Pendapatan YoY Margin Bersih ROE Margin Kotor
DMRA — — 38.3% -17981.1% -167.0% —
STOK $1.87B -264.5 404.5% -3.7% -2.0% —
ZBIO $1.98B -4.3 100.0% -3777.4% -156.8% —
AGIO $1.59B -3.8 48.0% -764.0% -32.2% —
TSHA $1.57B -16.2 17.3% -1115.3% -44.0% —
GENB — — — — — —
SRPT $2.26B -3.0 15.6% -32.5% -57.1% —
SNDX $1.84B -6.4 627.8% -165.6% -257.1% —
ANAB — -105.4 157.0% — — —
NTLA $1.05B -2.4 16.9% -609.8% -59.5% —

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

Laporan Laba Rugi 13
Data Laporan Laba Rugi Tahunan untuk DMRA
Metrik Tren 2025202420232022202120202019
R&D Expense 7-point trend, +36.2% $27M $6M $24M $48M $38M $25M $20M
SG&A Expense 7-point trend, +296.1% $10M $10M $13M $13M $14M $9M $2M
Operating Expenses 7-point trend, +441.1% $211M $22M $40M $61M $52M $34M $39M
Operating Income 7-point trend, -641.1% $-211M $-22M $-40M $-61M $-52M $-34M $39M
Other Non-op 7-point trend, -56.0% $1M $862.0K $2M $-417.0K $475.0K $-1M $2M
Pretax Income 7-point trend, -474.7% $-210M $-21M $-38M $-62M $-52M $-35M $-37M
Income Tax 7-point trend, +50000.00 $50.0K $41.0K $0 $0 $0 $0 $0
Net Income 7-point trend, -474.8% $-210M $-21M $-38M $-62M $-52M $-35M $-37M
EPS (Basic) 5-point trend, +294.1% $3.98 $-18.53 $-36.08 $-2.43 $-2.05 · ·
EPS (Diluted) 5-point trend, +294.1% $3.98 $-18.53 $-36.08 $-2.43 $-2.05 · ·
Shares (Basic) 5-point trend, -94.6% 1,363,005 1,157,149 1,062,873 25,409,123 25,261,832 · ·
Shares (Diluted) 5-point trend, -94.6% 1,363,005 1,157,149 1,062,873 25,409,123 25,261,832 · ·
EBITDA 6-point trend, -726.9% $-211M $-22M $-40M $-61M $-52M $34M ·
Neraca 21
Data Neraca Tahunan untuk DMRA
Metrik Tren 2025202420232022202120202019
Cash & Equivalents 7-point trend, +2181.1% $258M $14M $21M $33M $63M $164M $11M
Short-term Investments 3-point trend, -68.9% · · $12M $27M $38M · ·
Prepaid Expense 7-point trend, -45.3% $3M $3M $4M $4M $10M $6M $5M
Current Assets 7-point trend, +364.4% $260M $17M $37M $64M $110M $169M $56M
PP&E (Net) 5-point trend, -82.3% $36.0K $57.0K $78.0K $357.0K $203.0K · ·
PP&E (Gross) 5-point trend, -51.6% $108.0K $107.0K $107.0K $419.0K $223.0K · ·
Accum. Depreciation 5-point trend, +260.0% $72.0K $50.0K $29.0K $62.0K $20.0K · ·
Other Non-current Assets 6-point trend, -91.0% $104.0K $163.0K $1M $2M $2M $1M ·
Total Assets 7-point trend, +360.2% $261M $17M $38M $73M $122M $172M $57M
Accounts Payable 7-point trend, -86.7% $444.0K $377.0K $2M $3M $2M $3M $3M
Accrued Liabilities 7-point trend, -47.8% $2M $820.0K $4M $8M $3M $3M $5M
Current Liabilities 7-point trend, +153.1% $20M $1M $6M $11M $5M $6M $8M
Capital Leases 7-point trend, -74.9% $53.0K $61.0K $66.0K $328.0K $448.0K $541.0K $211.0K
Other Non-current Liabilities 2-point trend, +88.4% $81.0K $43.0K · · · · ·
Total Liabilities 7-point trend, +147.6% $20M $1M $6M $11M $5M $6M $8M
Paid-in Capital 7-point trend, +37513.6% $311M $292M $288M $280M $274M $269M $826.0K
Retained Earnings 7-point trend, -601.0% $-487M $-278M $-256M $-218M $-156M $-104M $-70M
AOCI 7-point trend, +132.7% $802.0K $97.0K $380.0K $-244.0K $-320.0K $674.0K $-2M
Stockholders' Equity 7-point trend, +437.9% $240M $16M $32M $62M $117M $165M $-71M
Liabilities + Equity 7-point trend, +360.2% $261M $17M $38M $73M $122M $172M $57M
Shares Outstanding 7-point trend, +514.4% 1,597,321 1,316,989 1,084,509 25,652,392 25,261,832 25,261,832 259,966
Arus Kas 10
Data Arus Kas Tahunan untuk DMRA
Metrik Tren 2025202420232022202120202019
Stock-based Comp 6-point trend, +1.6% $998.0K $3M $5M $6M $4M $982.0K ·
Restructuring 2-point trend, -71.9% · $968.0K $3M · · · ·
Operating Cash Flow 7-point trend, +65.2% $-7M $-19M $-37M $-43M $-52M $-38M $-19M
CapEx 2-point trend, -12.1% · · · $196.0K $223.0K · ·
Investing Cash Flow 6-point trend, -5229.4% $-17M $12M $22M $12M $-48M · $-326.0K
Stock Issued 2-point trend, +467.3% · · $3M $507.0K · · ·
Net Stock Activity 2-point trend, +467.3% · · $3M $507.0K · · ·
Financing Cash Flow 4-point trend, +42.4% $267M · $3M $507.0K · $187M ·
Taxes Paid $5.0K · · · · · ·
Free Cash Flow 2-point trend, +17.9% · · · $-43M $-53M · ·
Profitabilitas 7
Data Profitabilitas Tahunan untuk DMRA
Metrik Tren 2025202420232022202120202019
Operating Margin 5-point trend, +46.0% -18069.6% -2637.4% -2362.6% -8477.4% -33478.8% · ·
Net Margin 5-point trend, +45.8% -17981.1% -2540.2% -2270.5% -8535.2% -33174.4% · ·
Pretax Margin 5-point trend, +45.8% -17976.8% -2535.3% -2270.5% -8535.2% -33174.4% · ·
EBITDA Margin 5-point trend, +46.0% -18069.6% -2637.4% -2362.6% -8477.4% -33478.8% · ·
ROA 6-point trend, -395.1% -151.2% -77.5% -68.8% -63.1% -35.2% -30.5% ·
ROE 6-point trend, -76.8% -167.0% -116.6% -110.0% -91.6% -41.9% -94.5% ·
ROIC 6-point trend, -531.6% -87.8% -140.9% -123.4% -99.1% -44.5% 20.3% ·
Likuiditas & Solvabilitas 2
Data Likuiditas & Solvabilitas Tahunan untuk DMRA
Metrik Tren 2025202420232022202120202019
Current Ratio 6-point trend, -57.3% 13.0 14.1 6.3 5.8 24.2 30.4 ·
Quick Ratio 6-point trend, -56.3% 12.8 11.8 5.7 5.4 22.0 29.4 ·
Efisiensi 1
Data Efisiensi Tahunan untuk DMRA
Metrik Tren 2025202420232022202120202019
Asset Turnover 5-point trend, +663.6% 0.0 0.0 0.0 0.0 0.0 · ·
Per Saham 7
Data Per Saham Tahunan untuk DMRA
Metrik Tren 2025202420232022202120202019
Book Value / Share 6-point trend, +2197.2% $150.49 $12.02 $1.19 $2.41 $4.64 $6.55 ·
Revenue / Share 4-point trend, +2914.8% $0.86 $0.73 $0.06 $0.03 · · ·
Cash Flow / Share 4-point trend, -192.1% $-4.93 $-16.09 $-1.39 $-1.69 · · ·
Cash / Share 6-point trend, +2390.7% $161.29 $10.76 $0.79 $1.28 $2.48 $6.48 ·
Dividend / Share Flat — no change across 4 periods $0 $0 · · $0 $0 ·
Dividend Paid / Share Flat — no change across 2 periods · · · · $0 $0 ·
EPS (TTM) 5-point trend, +294.1% $3.98 $-18.53 $-36.08 $-2.43 $-2.05 · ·
Tingkat Pertumbuhan 2
Data Tingkat Pertumbuhan Tahunan untuk DMRA
Metrik Tren 2025202420232022202120202019
Revenue YoY 4-point trend, -89.5% 38.3% -50.0% 133.9% 362.8% · · ·
Revenue CAGR 3Y 2-point trend, -77.0% 17.4% 75.5% · · · · ·
Valuasi (TTM) 2
Data Valuasi (TTM) Tahunan untuk DMRA
Metrik Tren 2025202420232022202120202019
Revenue TTM 5-point trend, +648.1% $1M $844.0K $2M $722.0K $156.0K · ·
Net Income TTM 6-point trend, -502.3% $-210M $-21M $-38M $-62M $-52M $-35M ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

Laporan Laba Rugi
2025-12-312024-12-312023-12-312022-12-312021-12-31
Margin Operasi % -18069.6%-2637.4%-2362.6%-8477.4%-33478.8%
Laba Bersih $-210M$-21M$-38M$-62M$-52M
EPS Dilusian $3.98$-18.53$-36.08$-2.43$-2.05
Neraca
2025-12-312024-12-312023-12-312022-12-312021-12-31
Rasio Lancar 13.014.16.35.824.2
Rasio Cepat 12.811.85.75.422.0
Arus Kas
2025-12-312024-12-312023-12-312022-12-312021-12-31
Arus Kas Bebas ———$-43M$-53M

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

📊

Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

Orang dalam perusahaan 25 orang dalam · 11 pejabat · 14 direktur

Orang Dalam Peran Aktivitas terakhir Saham dimiliki Beli 12m Jual 12m Bersih 12m
Jennifer Jarrett President and Chief Executive Officer 30 Maret 2026 A 500.000 0 0 $0
Hans T. Schambye Chief Executive Officer 2 Jan. 2026 M 4.682 0 1 $-14.966
Lori Firmani Chief Financial Officer 2 Jan. 2026 M 931 0 1 $-2.890
Jonathan Freve Chief Financial Officer 3 Jan. 2024 A 12.000 0 0 $0
Sherwin Sattarzadeh Chief Operating Officer 5 Jan. 2026 A 190.376 0 0 $0
Anders Pedersen Chief Operating Officer 4 Jan. 2023 A 3.746 0 0 $0
Garrett Winslow General Counsel 3 Juli 2026 M 2.289 0 2 $-12.797
Becker L. Hewes Chief Medical Officer 5 Jan. 2026 A 264.629 0 0 $0
Matthew Kronmiller EVP Strategy and CBO 3 Jan. 2025 A — 0 0 $0
Stephanie Oestreich Chief Business Officer 4 Jan. 2023 A — 0 0 $0
Bertil Lindmark Chief Medical Officer 4 Jan. 2023 A 16.604 0 0 $0
Julianne Bruno Direktur 23 Maret 2026 A 137.032 0 0 $0
Christopher W. Cain Direktur 23 Maret 2026 A — 0 0 $0
Cameron Turtle Direktur 23 Maret 2026 A — 0 0 $0
Michael Landsittel Direktur 23 Maret 2026 A — 0 0 $0
Anne Prener Direktur 18 Juni 2025 A — 0 0 $0
Amy B Wechsler Direktur 18 Juni 2025 A — 0 0 $0
Jayson Donald Alexander Dallas Direktur 18 Juni 2025 A — 0 0 $0
Amit Munshi Direktur 18 Juni 2025 A 4.793 0 0 $0
David Shapiro Direktur 18 Juni 2025 A — 0 0 $0
Carl Goldfischer Direktur 18 Juni 2025 A 19.432 0 0 $0
Chau Quang Khuong Direktur 14 Juni 2023 A 1.031.811 0 0 $0
Stephan Christgau Direktur 2 Nov. 2020 C 546.136 0 0 $0
Novo Holdings A/S Pemilik 10% 2 Nov. 2020 C 2.497.791 0 0 $0
Andrew Cheng — 12 Agu 2026 A — 0 0 $0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Aktivis & pemilik 5%+ 3 saham

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju Diajukan Kepemilikan Status Tujuan Pengajuan
Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Fairmount Healthcare Co-Invest V L.P., Peter Evan Harwin, Tomas Kiselak ×2 pengajuan 11 Feb. 2026 19,99% Amandemen — SEC
Novo Holdings A/S ×6 pengajuan 9 Okt. 2025 0,00% Amandemen — SEC
OrbiMed Advisors LLC, OrbiMed Advisors Israel II Limited, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC, OrbiMed Capital LLC ×7 pengajuan 18 Sep. 2023 — Pengajuan awal — SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Kepemilikan ETF Dimiliki oleh 12 ETF

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana Bobot Unit Per tanggal Sumber
IWO · iShares Trust 0,07% 331.064 SH 8 Agu 2026 Harian
VTWG · VANGUARD SCOTTSDALE FUNDS 0,06% 39.408 SH 8 Agu 2026 Harian
IWM · iShares Trust 0,05% 1.337.645 SH 8 Agu 2026 Harian
VTWO · VANGUARD SCOTTSDALE FUNDS 0,04% 307.241 SH 8 Agu 2026 Harian
IWN · iShares Trust 0,03% 152.816 SH 8 Agu 2026 Harian
VTWV · VANGUARD SCOTTSDALE FUNDS 0,03% 14.454 SH 8 Agu 2026 Harian
OMFS · Invesco Exchange-Traded Self-Indexe… 0,03% 2.758 SH 8 Agu 2026 Harian
ISCB · iShares Trust 0,02% 2.013 SH 8 Agu 2026 Harian
WSML · iShares Trust 0,01% 2.534 SH 8 Agu 2026 Harian
VXF · VANGUARD INDEX FUNDS 0,01% 212.600 SH 8 Agu 2026 Harian
IWV · iShares Trust 0,00% 14.147 SH 8 Agu 2026 Harian
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 4.396 SH 8 Agu 2026 Harian